Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Pancreatic Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chaoyang District, China
Contact: Study coordinator (Lin YANG, Doctor)
Study leads
Lin Yang, Prof
Principal Investigator
LIN YA Cancer Institute and Hospital, Chinese Academy of Medical Sciences